Top 25 Healthcare AI Companies of 2025 Leading with Artificial Intelligence
The Healthcare Technology Report is pleased to announce The Top 25 Healthcare AI Companies of 2025. Artificial intelligence (AI) is profoundly transforming the pace of medical advancements. By tackling massive datasets, streamlining workflows, accelerating clinical trials, and optimizing patient care, this technology has become an essential ally for providers, health systems, and researchers alike. The recipients of this year’s award are empowering the healthcare industry and freeing up valuable resources, allowing professionals to shift their focus to what matters most: patients.
AI is not only boosting efficiency but has also become a key enabler for a more proactive and personalized healthcare model. Innovators such as K Health with its virtual primary care, Athelas’s remote patient monitoring solutions, and Quer.ai’s diagnostic tools designed for underserved areas are revolutionizing patient care delivery and improving access to vital services. Beyond enhancing the patient experience, AI and machine learning technology are also significantly enhancing the drug discovery pipeline. Companies like PathAI are training advanced AI models on large-scale, expertly annotated datasets to improve clinical trial support, while EvolutionaryScale’s technology enables researchers to simulate evolutionary processes and create novel proteins for therapeutic applications. These developments highlight the growing impact of healthcare artificial intelligence companies in shaping the future of medicine.
From sophisticated data analytics and diagnostics to administrative processes and groundbreaking research, this year’s awardees have identified pioneering ways to utilize AI to augment healthcare delivery at scale. Crucially, they have also implemented this technology with integrity, recognizing the critical importance of safety, rigorous validation, and responsible deployment.
Carefully selected based on meticulous criteria and thoughtful consideration of each company’s significant contributions to the field, this year’s awardees are firmly positioned as leaders not just in the AI domain but within the broader healthtech industry. We invite you to join us in recognizing The Top 25 Healthcare AI Companies of 2025 for their impactful work.
1. Cera
alt=”Logo or graphic representing Cera, a healthcare AI company”
Cera is a digital-first company specializing in home healthcare, delivering technology-enabled services across both the UK and Germany. Established in 2016, the company facilitates over 60,000 in-home patient appointments daily through its extensive network of carers and nurses, offering a comprehensive suite of services that includes nursing support, telehealth consultations, and medication management. Its innovative model is strategically designed to shift healthcare delivery away from traditional hospital settings and into the comfort and familiarity of patients’ homes, serving a population exceeding 30 million people on behalf of governmental bodies, insurance providers, and national health systems.
Cera’s sophisticated platform integrates real-time data monitoring with advanced machine learning algorithms to support critical clinical decision-making and optimize care coordination. By equipping healthcare professionals with intelligent tools that enable earlier detection of changes in patient health, the company has achieved significant reductions in hospital admissions and notable improvements in patient outcomes at scale. Leveraging one of the largest home healthcare datasets globally, Cera remains committed to developing and deploying cutting-edge AI tools to modernize care delivery and provide aging populations with highly personalized services within their homes.
2. XpertDox
Founded in 2015, XpertDox is a healthcare data analytics company based in Arizona, specializing in autonomous medical coding solutions. XpertDox has rapidly emerged as a leading provider of AI-powered autonomous coding for a diverse range of healthcare providers including urgent care chains, pediatric clinics, primary care organizations, women’s care organizations, federally qualified health centers (FQHCs) or community health centers (CHCs), and also billing and RCM companies. Their focus on automating complex coding tasks addresses a critical need in the industry.
XpertDox’s core medical coding platform, XpertCoding, harnesses the power of Artificial Intelligence (AI), Natural Language Processing (NLP), and Big Data Analytics. This combination allows it to automatically code over 94% of claims without requiring human intervention, achieving impressive coding accuracy exceeding 99%. The platform boasts EHR-agnostic compatibility, meaning it integrates seamlessly with most Electronic Health Record (EHR) systems. Furthermore, it includes a robust business intelligence suite offering detailed data analytics, a transparent audit trail, a performance dashboard, and Clinical Documentation Improvement (CDI) modules, providing healthcare organizations with invaluable operational insights.
In 2024, XpertDox formed a strategic partnership with Nao Medical, a multi-specialty healthcare provider in New York, specifically to enhance Nao Medical’s revenue cycle management operations through the application of AI. Following the implementation, Nao Medical reported a significant 15% increase in charge capture, a 60% improvement in quality code capture, and a 40% reduction in charge entry lag, demonstrating tangible operational improvements. In both 2023 and 2024, XpertDox successfully more than doubled its client base each year, indicating strong market traction. XpertDox places a strong emphasis on the responsible and ethical use of AI within healthcare operations. To uphold this commitment, it maintains critical certifications including ISO 22301 (Business Continuity Management), HIPAA compliance, ISO 27001 (Information Security Management), and SOC 2 (AICPA Type 2).
3. Tempus
Tempus is a healthcare technology company with a core focus on advancing precision medicine through the sophisticated use of artificial intelligence. By expertly processing vast amounts of complex clinical and molecular data, Tempus empowers physicians to make real-time, data-driven decisions tailored for personalized patient care. Its comprehensive platform effectively combines advanced analytics, machine learning models, and state-of-the-art diagnostic assays to yield critical insights. These insights are instrumental in identifying targeted therapies, accurately predicting patient responses to treatment, and connecting patients with relevant clinical trials across a broad spectrum of diseases.
Beyond providing direct support to frontline clinicians, Tempus actively collaborates with leading research institutions and life sciences partners to accelerate the pace of therapeutic discovery and development. The company’s innovative solutions encompass sophisticated data integration tools, advanced algorithmic models, and AI-enabled assistants specifically designed to help bridge gaps in care delivery and inform crucial clinical research initiatives. Driven by a compelling mission to continuously improve patient outcomes by learning from every single case, Tempus is dedicated to making individualized medicine more accessible and actionable for a wider population.
4. Augmedix
Augmedix specializes in developing AI-powered ambient documentation tools aimed at significantly reducing the administrative workload within busy healthcare settings. Its intelligent platform is designed to capture natural, spontaneous conversations between clinicians and patients and seamlessly convert them into structured medical notes, organized data entries, and timely point-of-care notifications. The overarching goal is to streamline essential clinical workflows and provide robust support for decision-making, all without disrupting the vital interaction and connection between the healthcare provider and the patient.
Widely adopted across numerous hospitals and extensive health systems, Augmedix’s advanced tools are specifically engineered to enhance operational efficiency and effectively combat clinician burnout by automating tedious documentation tasks. Leveraging data derived from millions of real-world clinical interactions, the company’s versatile solutions integrate smoothly into a wide variety of care environments and are currently supporting close to half a million clinicians. Through the innovative application of its technology, Augmedix endeavors to help healthcare professionals reclaim valuable time and refocus their energy and attention squarely on providing optimal patient care. Such advancements illustrate the growing influence of artificial intelligence in the workplace within the healthcare sector.
5. Verantos
Verantos is a real-world evidence (RWE) company based in the heart of Silicon Valley, specializing in the generation of high-validity data suitable for clinical, regulatory, and reimbursement applications. Its sophisticated platform excels at integrating and enriching data sourced from electronic health records, claims databases, and patient registries. By applying advanced artificial intelligence and meticulous data curation techniques, Verantos produces clinically robust, research-grade evidence. Their sharp focus on ensuring data completeness, traceability, and absolute accuracy provides critical support for applications spanning numerous therapeutic areas and various stages of the product lifecycle.
The company actively partners with leading pharmaceutical and biotechnology firms, esteemed academic medical centers, and federal agencies to support key initiatives in market access, medical affairs, pharmacovigilance, and regulatory science. Verantos has played a significant and instrumental role in advancing national data policy frameworks and has been specifically selected for prestigious demonstration projects by organizations such as the FDA, NIH, and NSF. Their unique approach enables large-scale studies that effectively incorporate unstructured clinical information, offering a level of reliability and scalability that is absolutely critical for informed decision-making within the life sciences industry.
6. Sword Health
Sword Health is a pioneering digital health company that effectively combines artificial intelligence with specialized clinical expertise to deliver exceptional virtual care for musculoskeletal conditions, pelvic health issues, and injury prevention. Established in 2015 in Portugal, the company provides a comprehensive, end-to-end platform that seamlessly connects patients with licensed physical therapists and state-of-the-art AI-powered tools designed to support personalized treatment plans and facilitate recovery. Its innovative approach is specifically crafted to improve patient access to high-quality care while significantly reducing the need for inconvenient in-person visits, potentially avoidable surgeries, and costly interventions.
Sword Health’s distinct model is termed “AI Care”—a sophisticated system that pairs expert human clinicians with intelligent AI-driven guidance to efficiently scale care delivery and significantly enhance patient outcomes. The versatile platform is utilized to treat a wide spectrum of conditions, ranging from chronic pain management to postpartum recovery support, and includes robust features for movement therapy guidance, efficient clinical coordination, and long-term prevention strategies. With a strong emphasis on accessibility and delivering measurable outcomes, Sword Health is dedicated to making world-class care available to patients regardless of their geographical location or socioeconomic background.
7. K Health
K Health is a New York-based company providing AI-driven virtual primary care services. Its user-friendly platform offers 24/7 access to qualified clinicians via a convenient mobile app and partners with leading health systems and insurance providers, extending its reach to millions of users across the United States. The service effectively covers a wide range of healthcare needs, from urgent care consultations and chronic condition management to essential mental health support, all with the primary goal of making high-quality healthcare significantly more accessible and affordable for everyone.
K Health leverages clinical-grade medical chat interfaces and advanced predictive AI models that have been meticulously trained on vast datasets of health information. These powerful tools are designed to support physicians by analyzing symptoms and reviewing comprehensive patient history to inform accurate diagnosis and effective treatment decisions. By skillfully combining cutting-edge machine learning capabilities with essential human oversight, K Health is successfully working towards reducing healthcare costs, improving the efficiency of care delivery, and enabling clinicians to focus more intently on achieving optimal patient outcomes.
8. PathAI
PathAI is a company dedicated to developing advanced artificial intelligence solutions specifically for digital pathology, with a strong focus on improving the accuracy of disease diagnosis and accelerating drug development pipelines. Its sophisticated AI models are trained on large-scale, meticulously expertly annotated datasets to support the precise analysis of complex tissue samples, empowering pathologists to detect subtle disease markers with greater precision. Driven by a commitment to improving patient outcomes through AI-powered pathology, PathAI’s cutting-edge technology is actively utilized in both clinical diagnostics and research settings, particularly within the field of oncology, to assist in areas such as diagnostics, biomarker discovery, and clinical trial support.
In addition to providing powerful diagnostic tools, PathAI collaborates closely with pharmaceutical companies and pathology laboratories to enhance laboratory workflows and accelerate therapeutic development. The company’s innovative platform seamlessly combines computational expertise with deep medical insight to support more efficient and confident clinical decision-making processes, streamlining analysis workflows and ultimately helping to bring effective new treatments to patients more quickly.
9. RapidAI
RapidAI is a medical technology company that specializes in providing AI-powered imaging solutions specifically designed for vascular and neurovascular conditions. Originally developed at the prestigious Stanford University and now utilized in over 100 countries worldwide, its flagship Rapid® platform provides crucial assistance to physicians in the rapid identification of critical conditions such as strokes, aneurysms, pulmonary embolisms, and other acute medical emergencies. The intelligent software analyzes high-resolution CT and MRI scans in real time, enabling significantly faster diagnosis and more timely treatment decisions across both emergency departments and inpatient settings.
With an impressive track record of processing more than 14 million scans globally, RapidAI’s platform has undergone rigorous validation through numerous multicenter clinical trials and is now seamlessly integrated into the care workflows at over 2,000 hospitals. Its versatile tools cover a growing range of critical use cases, including efficient patient triage, sophisticated perfusion imaging analysis, and precise treatment planning support. By effectively combining cutting-edge AI technology with decades of extensive clinical research, RapidAI is demonstrably improving care coordination and enhancing patient outcomes in time-sensitive, high-acuity medical scenarios.
10. CodaMetrix
CodaMetrix is a healthcare technology company that specializes in providing AI-powered autonomous medical coding solutions. Developed initially within the esteemed Mass General Brigham system, its advanced NLP-based platform is designed to accurately translate complex clinical documentation extracted from electronic health records into appropriate billing codes across a multitude of medical specialties. The system is intelligently engineered to significantly reduce administrative burdens, improve the accuracy of medical coding, and streamline the reimbursement process by continuously learning from incoming clinical data while diligently incorporating the latest payer rules and compliance requirements.
By strategically focusing on the most complex and often costly stage of the revenue cycle—the mid-cycle coding process—CodaMetrix empowers providers to optimize their operational efficiency and reduce reliance on laborious manual processes. Its innovative hybrid model effectively integrates essential human oversight for handling outlier cases and complex scenarios while scaling automation for routine and straightforward workflows. Serving a large network of over 200 hospitals and supporting more than 50,000 providers, CodaMetrix’s ambitious goal is to fundamentally reshape the role of medical coding, transforming it into a more efficient, reliable source not only for generating revenue but also for providing broader, actionable clinical insights. This demonstrates the significant impact of artificial technology in healthcare.
11. Athelas
Athelas develops advanced AI-powered platforms and integrated connected devices aimed at supporting effective chronic disease management and streamlining healthcare operations. Its sophisticated remote patient monitoring tools enable clinicians to conveniently track vital signs such as blood pressure, blood glucose levels, and patient weight through easily internet-connected devices. This capability facilitates timely medical interventions without the necessity for frequent in-person patient visits. Additionally, the company offers an innovative ambient AI transcription service that automatically generates clinical documentation, helping healthcare providers capture and organize patient data much more efficiently.
Beyond its clinical tools, Athelas also provides comprehensive revenue cycle management (RCM) services meticulously designed to improve billing workflows and maximize reimbursements for healthcare organizations. Its fully integrated software suite delivers real-time, actionable insights into financial operations, covering everything from initial claims processing to denials management. Driven by a shared frustration with outdated, antiquated medical billing systems, Athelas is committed to modernizing healthcare delivery processes for both clinicians and administrators alike.
12. Imagene
Imagene stands as a pioneering company in the field of AI-powered precision oncology, with a clear mission to make cancer research and diagnostics more accessible, scalable, and effective within real-world healthcare settings. The company expertly utilizes AI technology to capture complex features and intricate patterns residing within biopsy images and various omics data modalities, fundamentally transforming the landscape of clinical research and diagnostics. Imagene empowers life sciences companies, pharmaceutical firms, and clinical institutions to significantly accelerate biomarker discovery, optimize the design and execution of clinical trials, and deliver faster, more precise cancer diagnostics. Founded in 2020 and headquartered in the United States, Imagene has secured investment from leading figures, including Larry Ellison.
At the technological core of Imagene’s platform lies CanvOI, a cutting-edge Oncology Intelligence Foundation Model developed in close collaboration with Oracle. This model is designed to be scalable, generalizable, and exceptionally versatile, delivering robust performance even in scenarios with limited data where traditional models often struggle. It serves as the robust backbone of OI Suite, Imagene’s transformative platform for AI-driven cancer research and diagnostics, effectively supporting the full spectrum of oncology innovation—from initial diagnostics to comprehensive biomarker discovery and advanced drug development. By providing rapid, reliable insights into complex disease mechanisms and intricate tumor microenvironments, the platform assists partners in accelerating biomarker-driven therapeutic strategies and advancing the field of precision medicine. OI Suite enables life sciences and pharmaceutical teams to efficiently build and deploy sophisticated AI-powered models rapidly, notably without requiring deep machine learning expertise. This capability empowers partners to scale precision medicine and translational research efforts efficiently, even when operating in complex or resource-constrained environments.
13. Generate:Biomedicines
Generate:Biomedicines is a leading biotechnology company based in Massachusetts that employs advanced machine learning and generative biology techniques to design entirely novel protein therapeutics. Established in 2018, the company has successfully built a powerful platform that learns from analyzing millions of existing proteins to effectively model the intricate relationship between molecular structure and biological function. This foundational understanding enables the sophisticated generation of entirely new molecules specifically designed with therapeutic intent. Its groundbreaking work spans multiple critical areas within medicine, including immunology, oncology, and infectious diseases.
By seamlessly integrating cutting-edge computational methods with advanced biological engineering principles, Generate:Biomedicines aims to significantly increase both the speed and the success rate of the drug development process. The company has generated and rigorously tested tens of thousands of unique proteins to date. Its versatile platform supports the creation of drugs across several different modalities, strategically positioning it to address a wide range of pressing clinical needs. With an ambitious goal to effectively bring innovative ideas and cutting-edge science together, Generate:Biomedicines is pioneering the exciting field of generative biology.
14. Aidoc
Aidoc is a prominent healthtech company founded in 2016 and headquartered in Israel, focusing intently on developing AI-driven medical imaging solutions designed to support real-time clinical decision-making. Its algorithms, which hold both FDA and CE approval, provide critical assistance in identifying urgent medical conditions such as strokes, pulmonary embolisms, intracranial hemorrhages, cervical fractures, and intra-abdominal free gas. By effectively automating triage processes and rapidly flagging urgent findings, Aidoc helps radiologists and care teams prioritize high-risk cases significantly more efficiently.
The company’s robust platform, built upon its proprietary aiOS™ operating system, is specifically designed to integrate seamlessly across diverse healthcare systems and clinical workflows. Rather than offering isolated tools, Aidoc provides a comprehensive enterprise-level solution that aggregates and analyzes imaging data to support coordinated, timely medical interventions. Its overarching goal is to effectively reduce informational silos within care delivery while enabling faster, more informed decisions across various medical specialties.
15. MDI Health
MDI Health represents the next evolutionary step in medication management, effectively harnessing the power of AI to measurably enhance clinical outcomes, significantly reduce costs, and demonstrably improve quality measures—all consolidated within a single, integrated platform. MDI Health is actively engaged in combating the silent epidemic of Drug-Related Problems, tragically one of the leading causes of death in the US and incurring an estimated annual cost of $528 billion. MDI’s advanced technology empowers payers and providers across the nation to optimize medication treatment plans, driving thousands of dollars in annual savings per high-risk patient while simultaneously achieving significant reductions in the overall medication burden. Their award-winning system offers an unprecedented, comprehensive analysis of each individual patient and autonomously generates highly personalized clinical recommendations meticulously designed to improve quality metrics and directly reduce prescription and medical spend.
Leveraging sophisticated advanced algorithms, MDI’s cutting-edge technology performs in-depth personalized analyses across the entire patient population, diligently analyzing thousands of individual factors. These factors include patients’ current medications, their existing health conditions, recent lab values, demographic information, and much more. The system instantly generates tailored recommendations for necessary medication regimen changes. These recommendations are meticulously designed to prevent potential medical complications and are directly linked to closing quality gaps and achieving significant cost reduction objectives. This truly holistic approach, which was previously unattainable on a large scale, facilitates substantial improvements in patients’ overall health outcomes.
16. Insitro
Insitro was founded in 2018 by Daphne Koller with the ambitious goal of using sophisticated machine learning techniques to decode complex human biology and ultimately develop transformative new medicines. Seeking to fundamentally address the persistently low success rate in therapeutic research and development, its innovative platform utilizes data-driven predictions to generate crucial insights and purposefully design targeted treatments. Insitro’s powerful machine learning engine, when combined with access to large, high-quality, and multimodal datasets, significantly simplifies the process of demystifying intricate disease biology and, as a result, accelerates the development of novel treatments.
The company effectively leverages a highly cross-functional team comprised of expert scientists, skilled engineers, and other specialists to achieve its central goal: bringing the right drugs to the specific patients who need them most, quickly and efficiently. Insitro’s AI- and ML-based platform strategically harnesses genetic data, extensive human cohort data, and detailed cellular data to accelerate the entire drug discovery and development pipeline. Its unique company culture fosters a deliberately “bilingual” environment where scientists and technologists are actively encouraged to learn each other’s specialized “languages,” further emphasizing its profound commitment to utilizing truly interdisciplinary approaches to significantly advance the field of drug research and development.
17. Suki
Suki is a health technology company dedicated to developing advanced AI-powered voice tools designed to assist busy clinicians with routine administrative tasks. Its core product, Suki Assistant, functions as an intuitive voice-enabled AI assistant that significantly helps physicians complete clinical documentation, issue clear patient instructions, and manage complex forms through natural language commands. Specifically designed to reduce the substantial amount of time spent on burdensome paperwork, the versatile platform supports more efficient workflows across a wide variety of medical specialties and diverse care settings.
In direct response to the rising levels of clinician burnout across the industry, Suki aims to fundamentally reimagine the healthcare technology stack as a more intuitive, assistive layer that integrates seamlessly into existing clinical workflows. The company also strategically licenses its proprietary technology through the Suki Platform, which actively enables partners to incorporate cutting-edge voice-driven AI features—such as ambient documentation capture and efficient voice-based form filling—directly into their own existing solutions. By effectively combining state-of-the-art speech recognition capabilities, advanced large language models, and contextually relevant medical data, Suki is diligently building a scalable AI layer specifically intended to reduce administrative overhead and provide robust support for clinical decision-making processes across all healthcare settings.
18. Cleerly
Established in 2017, Cleerly is a cardiovascular imaging company intently focused on utilizing artificial intelligence to accurately assess heart disease through advanced non-invasive imaging techniques. Its innovative platform meticulously analyzes 3D coronary computed tomography angiography (CCTA) scans to precisely identify and measure atherosclerosis and other critical markers indicative of coronary artery disease. The company’s tools are specifically designed to provide clinicians with highly detailed, quantifiable insights into patient heart health, with the clear objective of supporting earlier, more informed decision-making processes without necessitating invasive medical procedures.
Cleerly’s foundational approach is deeply informed by nearly two decades of extensive research and comprehensive data gathered from large-scale, multi-center clinical trials. By effectively combining sophisticated AI technology with expert-validated methodologies, the company enables more precise evaluations of plaque presence, ischemia, and stenosis severity. Its cutting-edge solutions are intended to significantly improve diagnostic accuracy and facilitate clearer, more effective communication between healthcare providers and their patients regarding the management of cardiac care.
19. BigHat Biosciences
BigHat Biosciences is a leading biotechnology company actively advancing the development of safer, more effective antibody therapeutics through the utilization of its innovative AI-enabled discovery and engineering platform. Its flagship Milliner™ platform seamlessly integrates a high-speed synthetic biology laboratory with advanced machine learning capabilities to efficiently design, build, and rigorously test antibody candidates in rapid, iterative cycles. This sophisticated approach allows for the optimal optimization of key desirable properties—such as binding affinity, structural stability, target specificity, and reduced immunogenicity—thereby directly supporting the development of next-generation therapeutics aimed at treating a wide range of diseases, including various forms of cancer, inflammatory conditions, and infectious diseases.
Headquartered in the vibrant Bay Area and strongly supported by prominent investors such as Andreessen Horowitz, Amgen Ventures, and Bristol Myers Squibb, BigHat uniquely combines advanced automation, sophisticated computational design, and state-of-the-art wet-lab testing capabilities all under one roof. Its highly collaborative team of expert scientists and engineers works closely on both internal programs and external partnerships, applying its powerful platform to accelerate the process of hit discovery, effectively reduce development risks, and generate novel antibodies possessing complex, multi-target profiles that extend far beyond the capabilities of conventional biologic approaches.
20. Notable
Notable is a cutting-edge AI platform designed to automate critical healthcare operations across an extensive network exceeding 10,000 sites of care. Its intelligent tools efficiently handle over a million diverse workflows on a daily basis. These workflows encompass a wide range of essential tasks, including patient scheduling, intake processes, referral management, detailed chart review, and timely care gap closure initiatives, ultimately helping providers significantly reduce manual administrative tasks and dedicating more time to improve patient care. By integrating directly into existing clinical and operational systems, Notable effectively supports health systems in streamlining processes, reducing overall overhead costs, and enabling more personalized and efficient care experiences for patients.
Founded in 2017, Notable actively partners with hospitals and health systems of varying sizes to measurably improve both financial and clinical outcomes through scalable automation solutions. Its platform is specifically designed to alleviate the administrative burden placed upon valuable staff and clinicians while simultaneously enhancing operational efficiency across all departments. Providing support to major healthcare systems such as Presbyterian, Sanford Health, and Fort HealthCare, Notable is dedicated to helping healthcare providers deliver care more effectively and sustainably in today’s challenging environment.
21. Synthego
Synthego is a pioneering genome engineering company specializing in advanced CRISPR-based technologies tailored for life science research and the development of therapeutic solutions. The company offers a comprehensive range of solutions, from high-quality research-grade tools to materials suitable for IND-enabling studies and GMP-grade manufacturing, thereby providing crucial support to scientists throughout each critical stage of the drug development process. By seamlessly integrating advanced automation, sophisticated bioinformatics tools, and cutting-edge molecular biology techniques, Synthego delivers high-quality reagents and data-driven workflows specifically designed to streamline complex genome editing processes at scale.
Synthego serves both esteemed academic and commercial partners and has significantly contributed to over a dozen successful IND (Investigational New Drug) submissions. It is widely recognized and positioned as a key supplier within the rapidly evolving field of CRISPR-based therapy development. Its vertically integrated platform is intelligently designed to effectively reduce bottlenecks encountered during early discovery phases, preclinical validation stages, and crucial clinical manufacturing processes, all in dedicated pursuit of improving human health outcomes.
22. Formation Bio
Formation Bio strategically leverages AI and its proprietary technology to significantly improve the efficiency of clinical-stage drug development. The company acquires promising development-stage programs from established pharmaceutical firms, innovative biotech companies, and leading academic institutions, with the explicit goal of accelerating timelines and optimizing successful outcomes. Its unique approach integrates advanced software tools designed to streamline clinical trial design, facilitate efficient execution, and enhance the quality of collected data, ultimately helping to bring innovative treatments to patients faster and at a lower overall cost.
Formation Bio also actively collaborates with OpenAI and other key partners to collaboratively develop powerful AI-powered tools specifically for enhancing drug development processes and optimizing patient recruitment strategies. By effectively combining robust technical infrastructure with deep operational expertise, the company supports the execution of faster, more adaptive clinical trials across a wide range of therapeutic areas. Its sophisticated platform is engineered to reach clinical milestones earlier than traditional development models while consistently maintaining the highest standards of safety and adhering strictly to regulatory requirements.
23. Qure.ai
Qure.ai develops advanced artificial intelligence tools specifically designed to automate the complex interpretation of medical imaging, including X-rays, CT scans, and ultrasounds. Its intelligent AI models provide valuable assistance to clinicians in rapidly detecting and prioritizing critical conditions such as tuberculosis, lung cancer, and strokes, proving particularly invaluable in areas where access to specialized radiology expertise is limited. The company’s cutting-edge technology is designed to accelerate the speed of diagnosis, significantly improve workflow efficiency within imaging departments, and expand much-needed access to quality care, especially in resource-constrained settings.
Founded with the noble aim of making essential diagnostic services more equitable globally, Qure.ai partners with healthcare providers, public health programs, and esteemed research institutions across the world, operating effectively in over 100 countries through a network of 4,500 sites. Its versatile solutions support both critical clinical decision-making at the point of care and broader population health initiatives, effectively assisting medical teams in delivering timely interventions while efficiently managing high volumes of patients.
24. Hippocratic AI
Hippocratic AI is actively developing a safety-focused large language model (LLM) specifically designed and optimized for use within the healthcare domain. Established in 2023, the company aims to help address the significant global shortfall of healthcare workers by enabling safe, scalable support through intelligent AI-driven tools. Its advanced model is currently being developed in close collaboration with experienced clinicians, prominent hospital leaders, and leading researchers from prestigious institutions such as Stanford University, Johns Hopkins, and El Camino Health. A fundamental core design principle driving its development is the absolute necessity that its tools must perform at the safety level of an average competent clinician when executing any given task.
In addition to its significant technical development work, Hippocratic AI places a strong and deliberate emphasis on ethical AI development practices, consistently prioritizing patient safety, ensuring equitable access to care, and maximizing clinical utility. The company has successfully secured substantial funding from notable investors, including Andreessen Horowitz, General Catalyst, and NVIDIA’s NVentures, and is further supported by multiple healthcare systems. With a core mission deeply rooted in expanding access to essential care services and improving patient outcomes, Hippocratic AI is diligently exploring how generative AI technologies can effectively augment and enhance healthcare delivery systems.
25. EvolutionaryScale
EvolutionaryScale is a leading biotechnology company dedicated to developing frontier AI models aimed at significantly advancing the scientific understanding and sophisticated design of proteins. Its flagship model family, ESM3, is specifically built to interpret, generate, and perform complex reasoning over protein sequences, structures, and functions. Trained on billions of natural proteins and developed utilizing extensive large-scale computing power, ESM3 empowers researchers to simulate intricate evolutionary processes and create entirely novel proteins for a wide range of scientific and therapeutic applications.
The company also offers ESM Cambrian, a parallel model family specifically optimized for protein representation learning. EvolutionaryScale’s powerful tools are designed for widespread use across various life sciences disciplines, including crucial areas like drug discovery, environmental biology research, and the synthetic development of novel proteins. Its steadfast commitment to scientific rigor and responsible AI development is actively deepening our fundamental understanding of human biology, with far-reaching potential benefits for human health and broader society.
In conclusion, the companies recognized by The Healthcare Technology Report in their 2025 list represent the vanguard of integrating artificial intelligence into healthcare. Their innovative solutions are not only driving efficiency and reducing administrative burdens but are fundamentally transforming patient care, accelerating research, and broadening access to critical medical services. As these artificial intelligence in healthcare companies continue to mature and expand their capabilities, the impact of AI on the global health landscape is set to become even more profound, promising a future with more precise, accessible, and effective healthcare for all.
